Chinese english Germany Japanese Korea

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide Struktur
1874276-76-2
CAS-Nr.
1874276-76-2
Englisch Name:
3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide
Synonyma:
IDE-196;LXS-196;EOS-61826;NVP-LXS196;Darovasertib;LXS196,IDE196;LXS-196 (NVP-LXS196);Darovasertib (LXS-196);NVP-LXS196; NVPLXS196; NVP LXS196; LXS-196; LXS 196; LXS196; LXS-196;Protein kinase C,Darovasertib,IDE196,LXS-196,Inhibitor,PKC,LXS 196,IDE-196,IDE 196,inhibit
CBNumber:
CB33142692
Summenformel:
C22H23F3N8O
Molgewicht:
472.47
MOL-Datei:
1874276-76-2.mol
Request For Quotation

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide Eigenschaften

Siedepunkt:
592.7±50.0 °C(Predicted)
Dichte
1.387±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
Löslichkeit
DMF: 1 mg/ml; DMSO: 1 mg/ml; DMSO:PBS (pH 7.2) (1:6): 0.14 mg/ml
Aggregatzustand
A crystalline solid
pka
7.65±0.70(Predicted)

Sicherheit

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide Chemische Eigenschaften,Einsatz,Produktion Methoden

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 63)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
career henan chemical co 		+86-0371-86658258 15093356674;
 factory@coreychem.com China 29826 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6313 58
Labnetwork lnc. 		+86-27-50766799 +8618062016861
 contact@labnetwork.com China 19994 58
InvivoChem 		+1-708-310-1919 +1-13798911105
 sales@invivochem.cn United States 6393 58
TargetMol Chemicals Inc. 		+1-781-999-5354
support@targetmol.com United States 19973 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8474 58
Aladdin Scientific 		+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Guangzhou Biocar Biotechnology Co.,Ltd. +86-13397196830
 carrie@gzbiocar.cn China 436 58
Wuhan Shanhai Zhihe Biotechnology Co., Ltd. 17771424646
 shoubull@126.com China 965 58
Shanghai Boyle Chemical Co., Ltd.
sales@boylechem.com China 2923 55
  • 3-amino-N-(3-(4-amino-4-methylpiperidin-1-yl)pyridin-2-yl)-6-(3-(trifluoromethyl)pyridin-2-yl)pyrazine-2-carboxamide
  • LXS-196
  • NVP-LXS196
  • EOS-61826
  • NVP-LXS196; NVPLXS196; NVP LXS196; LXS-196; LXS 196; LXS196; LXS-196
  • IDE-196
  • LXS196,IDE196
  • 2-Pyrazinecarboxamide, 3-amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-
  • Darovasertib
  • Protein kinase C,Darovasertib,IDE196,LXS-196,Inhibitor,PKC,LXS 196,IDE-196,IDE 196,inhibit
  • LXS-196 (NVP-LXS196)
  • Darovasertib (LXS-196)
  • 1874276-76-2
  • C22H23F3N8O
Copyright 2019 © ChemicalBook. All rights reserved